Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jan 2019 15:40

RNS Number : 5327M
Caledonia Investments PLC
08 January 2019
Β 

Caledonia Investments plc

Director/PDMR Shareholding Notification

Β 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulation of the following transactions involving two of its directors, Jamie Cayzer-Colvin and William Wyatt, as detailed below.

Β 

On 8 January 2019, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Performance Share Scheme ("Performance Share Scheme") and Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") at nil cost. All shares were sourced from the Caledonia Investments plc Employee Share Trust ("EST") and subsequently sold back to the EST at 2907.5p per share on the same date.

Β 

Β 

No of shares transferred under the Performance Share Scheme at Β£nil

Β 

No of shares transferred under the Deferred Bonus Plan at Β£nil

Β 

No of shares sold

% of issued capital

JMB Cayzer-Colvin

Β 

14,358

10,670

25,028

0.05

WP Wyatt

Β 

23,352

17,784

41,136

0.07

Β 

Β 

Further information required by the EU Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Β 

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 January 2019

Β 

Β 

APPENDIXΒ 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares arising from 1 and 2 above

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

14,358

Β£0.00

Β 

10,670

Β 

Β£29.075

25,028

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

25,028 shares

Β 

Exercise of PSS awards/Call of DBP awards (Β£nil)

Β 

Sale of shares: Β£29.075

Β 

e)

Β 

Date of the transaction

Β 

8 January 2019

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

William Penfold Wyatt

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares arising from 1 and 2 above

Β 

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

23,352

Β 

Β£0.00

17,784

Β£29.075

41,136

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

41,136 shares

Β 

Exercise of PSS awards/Call of DBP awards (Β£nil)

Β 

Sale of shares: Β£29.075

Β 

e)

Β 

Date of the transaction

Β 

8 January 2019

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHSSAFIAFUSEDF
Date   Source Headline
23rd Jul 20154:47 pmRNSDirector/PDMR Shareholding
23rd Jul 20152:04 pmRNSDirector/PDMR Shareholding
16th Jul 201512:49 pmRNSResult of AGM
6th Jul 20153:08 pmRNSInterim Management Statement
6th Jul 20153:07 pmRNSNet Asset Value(s)
1st Jul 20151:09 pmRNSDirector/PDMR Shareholding
1st Jul 20159:45 amRNSBlocklisting Interim Review
26th Jun 20153:42 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSAcquisition
16th Jun 201510:24 amRNSAnnual Financial Report
4th Jun 20151:55 pmRNSNet Asset Value(s)
27th May 20157:00 amRNSFinal Results
11th May 20152:38 pmRNSHolding(s) in Company
11th May 20159:22 amRNSNet Asset Value(s)
30th Apr 201510:30 amRNSDirector Declaration
17th Apr 20153:51 pmRNSHolding(s) in Company
16th Apr 20154:10 pmRNSHolding(s) in Company
15th Apr 20159:15 amRNSHolding(s) in Company
14th Apr 20152:47 pmRNSHolding(s) in Company
14th Apr 20159:38 amRNSDirector Declaration
10th Apr 201512:30 pmRNSHolding(s) in Company
10th Apr 20159:12 amRNSNet Asset Value(s)
1st Apr 20152:58 pmRNSHolding(s) in Company
31st Mar 20154:44 pmRNSTransaction in Own Shares
25th Mar 20151:12 pmRNSDirector/PDMR Shareholding
20th Mar 20152:15 pmRNSHolding(s) in Company
18th Mar 20157:06 amRNSDirector Declaration
18th Mar 20157:00 amRNSDirectorate Change
9th Mar 20154:30 pmRNSSignificant holding in Company
9th Mar 20159:14 amRNSNet Asset Value(s)
9th Mar 20157:00 amRNSHolding(s) in Company
3rd Mar 201510:39 amRNSHolding(s) in Company
27th Feb 20155:28 pmRNSHolding(s) in Company
19th Feb 20152:17 pmRNSHolding(s) in Company
5th Feb 20152:31 pmRNSNet Asset Value(s)
26th Jan 201510:52 amRNSHolding(s) in Company
16th Jan 20154:30 pmRNSHolding(s) in Company
12th Jan 201510:45 amRNSHolding(s) in Company
8th Jan 201510:35 amRNSInterim Management Statement
8th Jan 201510:31 amRNSNet Asset Value(s)
2nd Jan 20157:00 amRNSBlocklisting Interim Review
18th Dec 20149:45 amRNSDirector/PDMR Shareholding
5th Dec 201410:44 amRNSNet Asset Value(s)
1st Dec 20144:40 pmRNSHolding(s) in Company
28th Nov 20149:19 amRNSDirector/PDMR Shareholding
25th Nov 201412:37 pmRNSHolding(s) in Company
25th Nov 20147:00 amRNSHalf Yearly Report
10th Nov 20149:22 amRNSNet Asset Value(s)
7th Oct 20143:20 pmRNSNet Asset Value(s)
30th Sep 20144:47 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.